Odonate Therapeutics, Inc. Operating Income
Odonate Therapeutics, Inc. reported Operating Income of -$14.02 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-11-10
- Odonate Therapeutics, Inc. operating income (loss) for the quarter ending 2021-09-30 was -$14.02M.
- Odonate Therapeutics, Inc. operating income (loss) for the quarter ending 2021-06-30 was -$22.05M.
- Odonate Therapeutics, Inc. operating income (loss) for the quarter ending 2021-03-31 was -$33.82M.
- Odonate Therapeutics, Inc. operating income (loss) for the quarter ending 2020-12-31 was -$32.43M.
- Odonate Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$127.43M.
- Odonate Therapeutics, Inc. operating income (loss) for fiscal 2019 was -$114.93M.
- Odonate Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$90.76M.
- Odonate Therapeutics, Inc. operating income (loss) for fiscal 2017 was -$32.74M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$14.02M 10-Q · filed 2021-11-10 | -$36.07M derived: sum of 2 quarters · filed 2021-11-10 | -$69.89M 10-Q · filed 2021-11-10 | -$102.32M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | -$22.05M 10-Q · filed 2021-07-27 | -$55.87M 10-Q · filed 2021-07-27 | -$88.31M derived: sum of 3 quarters · filed 2021-07-27 | -$118.96M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | -$33.82M 10-Q · filed 2021-05-14 | -$66.25M derived: sum of 2 quarters · filed 2021-05-14 | -$96.90M derived: sum of 3 quarters · filed 2021-11-10 | -$130.43M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | -$32.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$63.08M derived: sum of 2 quarters · filed 2021-11-10 | -$96.61M derived: sum of 3 quarters · filed 2021-11-10 | -$127.43M 10-K · filed 2021-02-23 |
| 2020-09-30 | -$30.65M 10-Q · filed 2021-11-10 | -$64.18M derived: sum of 2 quarters · filed 2021-11-10 | -$95.00M 10-Q · filed 2021-11-10 | -$123.71M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$33.53M 10-Q · filed 2021-07-27 | -$64.35M 10-Q · filed 2021-07-27 | -$93.06M derived: sum of 3 quarters · filed 2021-07-27 | -$120.82M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | -$30.82M 10-Q · filed 2021-05-14 | -$59.53M derived: sum of 2 quarters · filed 2021-05-14 | -$87.29M derived: sum of 3 quarters · filed 2021-05-14 | -$116.53M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$28.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$56.47M derived: sum of 2 quarters · filed 2021-02-23 | -$85.71M derived: sum of 3 quarters · filed 2021-02-23 | -$114.93M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$27.76M 10-Q · filed 2020-10-28 | -$57.00M derived: sum of 2 quarters · filed 2020-10-28 | -$86.22M 10-Q · filed 2020-10-28 | -$115.70M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | -$29.24M 10-Q · filed 2020-07-30 | -$58.46M 10-Q · filed 2020-07-30 | -$87.94M derived: sum of 3 quarters · filed 2020-07-30 | -$112.56M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | -$29.22M 10-Q · filed 2020-04-28 | -$58.70M derived: sum of 2 quarters · filed 2020-04-28 | -$83.33M derived: sum of 3 quarters · filed 2020-04-28 | -$103.11M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | -$29.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$54.10M derived: sum of 2 quarters · filed 2020-02-20 | -$73.88M derived: sum of 3 quarters · filed 2020-02-20 | -$90.76M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$24.63M 10-Q · filed 2019-11-06 | -$44.41M derived: sum of 2 quarters · filed 2019-11-06 | -$61.29M 10-Q · filed 2019-11-06 | -$77.03M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$19.78M 10-Q · filed 2019-07-24 | -$36.66M 10-Q · filed 2019-07-24 | -$52.41M derived: sum of 3 quarters · filed 2019-07-24 | -$62.78M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | -$16.88M 10-Q · filed 2019-04-25 | -$32.63M derived: sum of 2 quarters · filed 2019-04-25 | -$43.00M derived: sum of 3 quarters · filed 2019-04-25 | -$46.90M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | -$15.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$26.12M derived: sum of 2 quarters · filed 2019-02-22 | -$30.02M derived: sum of 3 quarters · filed 2019-02-22 | -$32.74M 10-K · filed 2019-02-22 |
| 2017-09-30 | -$10.37M 10-Q · filed 2018-10-23 | -$14.27M derived: sum of 2 quarters · filed 2018-10-23 | -$17.00M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | -$3.90M 10-Q · filed 2018-07-30 | -$6.63M 10-Q · filed 2018-07-30 |